| Dr Elizabeth Kilgour Hawkes, MD | |
|
2001 El Centro Familiar Blvd Sw, Albuquerque, NM 87105-4592 | |
| (505) 873-7400 | |
| Not Available |
| Full Name | Dr Elizabeth Kilgour Hawkes |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2001 El Centro Familiar Blvd Sw, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538160353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | G85127 (California) | Primary |
| Entity Name | Erie Family Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760499545 PECOS PAC ID: 9537050422 Enrollment ID: O20040322000689 |
News Archive
Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master regulator of thousands of other genes and may spur cancer cell growth and resistance to anticancer treatment.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced that the World Health Organization's International Nonproprietary Name group has accepted the proposed generic name "piclidenoson" for its lead drug candidate, CF101.
Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.
For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.
Working with human breast cancer cells and mice, researchers at Johns Hopkins say they have identified a biochemical pathway that triggers the regrowth of breast cancer stem cells after chemotherapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Kilgour Hawkes, MD 7015 Borg Rd Ne, Albuquerque, NM 87111-5883 Ph: (505) 298-1456 | Dr Elizabeth Kilgour Hawkes, MD 2001 El Centro Familiar Blvd Sw, Albuquerque, NM 87105-4592 Ph: (505) 873-7400 |
News Archive
Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master regulator of thousands of other genes and may spur cancer cell growth and resistance to anticancer treatment.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced that the World Health Organization's International Nonproprietary Name group has accepted the proposed generic name "piclidenoson" for its lead drug candidate, CF101.
Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.
For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.
Working with human breast cancer cells and mice, researchers at Johns Hopkins say they have identified a biochemical pathway that triggers the regrowth of breast cancer stem cells after chemotherapy.
› Verified 8 days ago
Janell Fuller, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3rd Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-2345 | |
Ivana Radovanovic, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Ne Acc 3w, Albuquerque, NM 87131 Phone: 505-272-6632 Fax: 505-272-6620 | |
Lynn Longfield, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4420 Irving Blvd Nw, Albuquerque, NM 87114 Phone: 505-823-1010 Fax: 505-797-4503 | |
Thomas Rothfeld, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 401 San Mateo Blvd Se, Pmg San Mateo, Albuquerque, NM 87108 Phone: 505-462-7306 Fax: 505-462-7495 | |
Dr. Leslie Erin Strickler, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-5551 Fax: 505-272-6845 | |
Jennifer M Garcia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2001 El Centro Familiar Blvd Sw, Albuquerque, NM 87105 Phone: 505-873-7400 Fax: 505-224-8797 | |
Dr. William B Hawk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5904 Holly Ave Ne, Albuquerque, NM 87113 Phone: 505-298-2505 Fax: 505-298-2985 |